Zymeworks (ZYME) Net earnings per share growth forecast for next year

Symbol and logo of brand Zymeworks Corp (ZYME)

Zymeworks Inc. is scaling its oncology antibody platform, leveraging multi-billion dollar international contracts. Production cycles and clinical trials are fully outsourced to third-party contractors, creating a critical dependency on partners. Sustainability is maintained through laboratory automation to minimize reagent use. The valuation of forward net income growth rates visualizes shifts in analyst sentiment, while the -39.70 mark records this indicator.

ZYME - Zymeworks Corp Earnings growth forecast for next year over the range 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for zymeworks.com (ZYME)

- price and consensus price forecast:
Price Chart Zymeworks Corp|ZYME - Consensus Target
- market capitalization details:
Market Value Zymeworks|ZYME - Real Price to Acquire Entire Company
- company book value details:
Accounting Value per Share Zymeworks|ZYME - Book Capitalization|Market Value to Book Value Ratio zymeworks.com|ZYME - Total Business Assets
- company liabilities and liquidity data:
Debt to Equity Zymeworks Inc.|ZYME - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Zymeworks|ZYME - Company Total Indebtedness|Debt to Book Value Zymeworks|ZYME - Amount of Long-Term Liabilities|Company Short-Term Debts Zymeworks|Quick Ratio zymeworks.com
- earnings and market ratios statistics:
ZYME - Company Net Income|Expected Profit Zymeworks Inc.|ZYME - Company Value to Net Income|Forward P/E Multiple Zymeworks Inc.|ZYME - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zymeworks|ZYME - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Zymeworks|ZYME - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months zymeworks.com|ZYME - Earnings per share trend in current year|Expected earnings per share growth for next year Zymeworks Inc.
Analysis of all company metrics:Zymeworks Corp
Core merchandise of Zymeworks Inc

For Zymeworks Inc. (ZYME), profit dynamics depend directly on the success of global clinical trials amid geopolitical fragmentation and sanction restrictions. By analyzing the consensus forecast for forward EPS growth rates, investors track the weighted average analyst expectations for changes in net income per share, where any sharp reversal of the trend line signals a revision of the business's fundamental value and a potential shift in market capitalization.

Direct competitors

Net earnings per share growth forecast for next year ImmunityBio Corp|Expected earnings per share growth for next year Immunocore Corp (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics (JANX)|Expected earnings per share growth for next year arcusbio.com RCUS|Tango Therapeutics, Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year Iovance Biotherapeutics Inc IOVA|IMTX - Net earnings per share growth forecast for next year|XNCR (Xencor Inc.) - Projected earnings per share growth rate for next year|Compass Therapeutics (CMPX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year replimune.com (REPL)|Expected earnings per share growth for next year LYEL|IPHA - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year PYXS (Pyxis Oncology, Inc.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech, Inc.)|Expected earnings per share trend next year STRO|MiNK Therapeutics - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics|immixbio.com (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings Inc. - Expected earnings per share trend next year|CUE (Cue Biopharma, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year PDS Biotechnology Corp|Net earnings per share growth forecast for next year Sonnet BioTherapeutics (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Corp - Expected earnings per share growth for next year|LAVA Therapeutics NV (LVTX) - Expected net earnings per share growth next year|NXTC: Expected earnings per share growth for next year|Net earnings per share change forecast for next year LPTX|INTS (intensitytherapeutics.com) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Sensei Biotherapeutics, Inc. (SNSE)|Net earnings per share growth forecast for next year Synthetic Biologics|Expected earnings per share growth for next year Gritstone Bio (GRTS)|Earnings growth forecast for next year KA|NEXI - Expected net earnings per share growth next year|Turnstone Biologics Corp. - Expected earnings per share growth for next year|VCNX - Expected earnings per share growth for next year|HARP - Net earnings per share growth forecast for next year